MEDIROM Healthcare Technologies Accounts Payable

MEDIROM Healthcare Technologies posts a accounts payable of $220M as of December 2025. That compares with $1B in the prior-year period — down 77.9% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, MEDIROM Healthcare Technologies's accounts payable was $1B. The latest reading is $220M — a 77.9% year-over-year decrease (period ending December 2025). Use the history and growth charts on this page for a longer lookback.

Accounts Payable is one piece of MEDIROM Healthcare Technologies's financial statement story. At $220M, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for MRM's accounts payable usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; MEDIROM Healthcare Technologies's other metric pages and overview cover the third.

Judging MEDIROM Healthcare Technologies against Consumer Discretionary peers is usually better than using a market-wide rule of thumb. Business models inside Consumer Discretionary are more comparable, which makes gaps in accounts payable easier to interpret. Start with $220M here, then scan peer and history charts to see if the gap is persistent.